Lymphoma is a medical condition with active clinical research programs worldwide.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT00003389	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma	COMPLETED	PHASE3
NCT00897767	Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	COMPLETED	—
NCT00217425	Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms	COMPLETED	PHASE2
NCT01359592	S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma	COMPLETED	PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT00070291	Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma	TERMINATED	PHASE2
NCT01412879	S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma	COMPLETED	PHASE2
NCT01239797	Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma	COMPLETED	PHASE3
NCT01415752	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING	PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—

Related Pages

All Lymphoma trials All trials in Skokie, United States